TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 12,900
+990 (8.31%)
At close: Apr 1, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 320.15 billion as of April 2, 2026. Its market cap has increased by 265.40% in one year.
Market Cap
320.15B
Enterprise Value
321.11B
Revenue
12.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,900.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has increased from 311.90B to 320.15B, an increase of 2.64%. That is a compound annual growth rate of 0.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 375.11B | 119.90% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 535.51B |
| Kanaph Therapeutics | 533.79B |
| Y-Biologics | 487.98B |
| Kangstem Biotech | 333.89B |
| curacle co.,ltd. | 320.41B |
| NIBEC | 317.11B |
| S.Biomedics | 309.01B |
| Bio Solution | 302.64B |